
Amazing.AI.
2.3K posts

Amazing.AI.
@amazing_AI_
I cover all issues relating to artificial intelligence. Visit my YouTube channel https://t.co/0OIKfGZ547





Trump Overnight Presidential Job Approval - is in. Single overnight approval for last night: 49.10% And he remains at 47% today in the 5-day rolling avg.



President Trump, from the South Portico of the White House, with the Easter Bunny, addresses Iran:



More than 70 migrants feared dead after overcrowded wooden boat capsizes off Libya. Up to 120 people were crammed onto the unseaworthy vessel that left Tajoura port and overturned in rough seas. Only 32 survivors — all male, from Pakistan, Bangladesh and Egypt (one a minor) were rescued by merchant ships and taken to Lampedusa. Just two bodies recovered so far, with dozens still missing and presumed drowned. Sea-Watch aircraft spotted desperate men clinging to the hull and bodies floating in the water.











🚨🚨@sama tells me he feels such URGENCY about the power of coming AI models that @OpenAI is unveiling a New Deal for superintelligence - ideas to wake up DC He says AI will soon be so mindbending that we need a new social contract 👇Altman's top 6 ideas axios.com/2026/04/06/beh…





Everyone's talking about retatrutide for weight loss (28.7%). Almost nobody's talking about what it does to your liver. More than 80% reduction in liver fat. Over 90% normalization rates. In a body composition substudy from the Phase 3 program. 100 million Americans have fatty liver disease. Most don't know it. There's no FDA-approved treatment for it besides "lose weight and hope." Retatrutide's glucagon receptor activation appears to directly target hepatic fat metabolism not just as a side effect of weight loss, but as a primary mechanism. This isn't a weight loss drug that happens to help your liver. It might be a liver drug that happens to cause weight loss. Phase 3 weight loss data drops first half of 2026. Watch this space.


















